nervapax ApS

CVR 44342170 · Private limited company (ApS) · Active · Low risk

nervapax ApS is a Private limited company (ApS), founded on , based in Hjallerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 445k and a net result of DKK -151k. CEO: Fridel de Fries Laursen, Meike Claudia Sieburg.

Bankruptcy risk for nervapax ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Negative equityNo · bankruptcy rate 5.1%0.58×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Number of CEOs2 · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44342170
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o Fridel de Fries Laursen, Vestergade 94
9320 Hjallerup
Municipality
Brønderslev
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 40k
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 2
Missing annual reportNo
Negative equityNo
Equity ratio51.7%
Current ratio151%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -29kDKK 1.4m
Net profitDKK -151kDKK 556k
EquityDKK 445kDKK 596k
Total assetsDKK 862kDKK 1.1m
CashDKK 72kDKK 255k
Short-term debtDKK 67kDKK 86k
Avg. employees02

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Grant Thornton, Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025182
2 Oct 2023 – 31 Dec 2024185 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOFridel de Fries LaursenCurrent
CEOMeike Claudia SieburgCurrent
Owner (100%)nervapax holding ApSCurrent
Foundernervapax holding ApSCurrent

The CEOs' other companies

Fridel de Fries Laursen – 1 other companies

Meike Claudia Sieburg – 1 other companies

Address history (0 moves)

c/o Fridel de Fries Laursen, Vestergade 94, 9320 Hjallerup

Other companies at the same address

Similar companies in Brønderslev

Questions and answers about nervapax ApS

Has nervapax ApS gone bankrupt?

No, nervapax ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of nervapax ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of nervapax ApS?

Fridel de Fries Laursen, Meike Claudia Sieburg are the CEOs of nervapax ApS.

Who is the auditor of nervapax ApS?

nervapax ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was nervapax ApS founded?

nervapax ApS was founded on 2 October 2023.

What is the equity of nervapax ApS?

Equity was DKK 445k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.